These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29083488)

  • 41. Talin1 and Rap1 are critical for osteoclast function.
    Zou W; Izawa T; Zhu T; Chappel J; Otero K; Monkley SJ; Critchley DR; Petrich BG; Morozov A; Ginsberg MH; Teitelbaum SL
    Mol Cell Biol; 2013 Feb; 33(4):830-44. PubMed ID: 23230271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
    Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
    FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.
    Song MK; Park C; Lee YD; Kim H; Kim MK; Kwon JO; Koo JH; Joo MS; Kim SG; Kim HH
    J Cell Mol Med; 2018 Feb; 22(2):849-860. PubMed ID: 29077264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
    Sharma SM; Sif S; Ostrowski MC; Sankar U
    J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling.
    Wang J; Xu C; Zhang J; Bao Y; Tang Y; Lv X; Ma B; Wu X; Mao G
    Mol Med; 2023 Apr; 29(1):49. PubMed ID: 37020186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway.
    Chawalitpong S; Sornkaew N; Suksamrarn A; Palaga T
    Eur J Pharmacol; 2016 Oct; 788():351-359. PubMed ID: 27523282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA-Jak3:Jak3 coexpressed pattern regulates monosodium urate crystal-induced osteoclast differentiation through Nfatc1/Ctsk expression.
    Lee CP; Huang YN; Nithiyanantham S; Huang CM; Ko YC
    Environ Toxicol; 2019 Feb; 34(2):179-187. PubMed ID: 30387921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NVP-BHG712 alleviates ovariectomy-induced osteoporosis by modulating osteoclastogenesis.
    Liu X; Liu S; Sun H; Zhang J; Li M; Shi Y; Wang G; Chen W; Cao Y; Lu G; Ning Y; Zhao Y
    Eur J Pharmacol; 2024 Nov; 983():177000. PubMed ID: 39278311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.
    Charles JF; Coury F; Sulyanto R; Sitara D; Wu J; Brady N; Tsang K; Sigrist K; Tollefsen DM; He L; Storm D; Aliprantis AO
    Bone; 2012 Nov; 51(5):902-12. PubMed ID: 22985540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
    J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis.
    Xu C; Wei Z; Lv L; Dong X; Xia W; Xing J; Liu H; Zhao X; Liu Y; Wang W; Jiang H; Gong Y; Liu C; Xu K; Wang S; Akimoto Y; Hu Z
    Biochem Biophys Res Commun; 2024 Oct; 727():150317. PubMed ID: 38959733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
    Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
    J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis.
    Jo YJ; Lee HI; Kim N; Hwang D; Lee J; Lee GR; Hong SE; Lee H; Kwon M; Kim NY; Kim HJ; Park JH; Kang YH; Kim HS; Lee SY; Jeong W
    J Cell Physiol; 2021 Mar; 236(3):1854-1865. PubMed ID: 32700766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
    Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
    J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation.
    Chen K; Yuan Y; Wang Z; Song D; Zhao J; Cao Z; Chen J; Guo Q; Chen L; Tickner J; Xu J
    J Cell Physiol; 2019 May; 234(5):6477-6488. PubMed ID: 30341897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.
    Park-Min KH; Lee EY; Moskowitz NK; Lim E; Lee SK; Lorenzo JA; Huang C; Melnick AM; Purdue PE; Goldring SR; Ivashkiv LB
    J Bone Miner Res; 2013 Jan; 28(1):135-49. PubMed ID: 22893614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.